Thompson NA, Stewart GD, Welsh SJ, Doherty GJ, et al. The MITRE trial protocol: a study to evaluate the microbiome as a biomarker of efficacy and toxicity in cancer patients receiving immune checkpoint inhibitor therapy. BMC Cancer 2022;22:99.
PMID: 35073853